Tetsuro Morota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tetsuro Morota has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Shinichi Takamoto
Department of Cardiothoracic Surgery, Faculty of Medicine, University of Tokyo, Japan
5 shared publications Minoru Ono
2 shared publicationsArata Murakami
Department of Cardiothoracic Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publication- Daisuke Yasui
Department of Radiology, Nippon Medical School, Tokyo, Japan
1 shared publication - Fumie Sugihara
Department of Radiology, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo, Tokyo 113-8603, Japan
1 shared publication - Hidemasa Saito
Department of Radiology, Nippon Medical School, Tokyo, Japan
1 shared publication
Latest Publications
- 1 August 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 75, 205-216
A Comparison of Outcomes Based on Vessel Type (Native Artery vs. Bypass Graft) and Artery Location (Below-Knee Artery vs. Non-Below-Knee Artery) Using a Combination of Multiple Endovascular Techniques for Acute Lower Limb Ischemia
- 1 August 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 75, 205-216
A Comparison of Outcomes Based on Vessel Type (Native Artery vs. Bypass Graft) and Artery Location (Below-Knee Artery vs. Non-Below-Knee Artery) Using a Combination of Multiple Endovascular Techniques for Acute Lower Limb Ischemia
- Open Access
- 27 January 2014
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 18 (5) , 556-560
Healing process of a novel zero-porosity vascular graft
We report on a study of thoracic aortic replacement in a canine model in order to demonstrate experimentally the process of tissue healing facilitated by the uniquely structured Triplex® graft.
- 27 January 2014
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 18 (5) , 556-560
Open AccessHealing process of a novel zero-porosity vascular graft
We report on a study of thoracic aortic replacement in a canine model in order to demonstrate experimentally the process of tissue healing facilitated by the uniquely structured Triplex® graft.
- 1 January 2013
- Published by The Editorial Committee of Annals of Vascular Diseases in Annals of Vascular Diseases
- Vol. 6 (1) , 67-73
Development and Physical Characteristics of Novel Zero-Porosity Vascular Graft “Triplex®^|^quot;
We developed a novel large-diameter graft "Triplex(®)" that uses a non-biodegradable material as a coating material. This time, in order to demonstrate the physical properties of Triplex(®) grafts, we conducted physical tests in accordance with the international guidelines, using the collagen coated vascular grafts (Hemashield, Boston Scientific, Natick, Massachusetts, USA) as the controls. The grafts were tested with regard to strength (burst strength, circumferential tensile strength, longitudinal tensile strength), suture retention strength, integral water permeability, water leakage (needle puncture, after using clamp), and change in luminal diameter following pacing stress according to ISO7198 and FDA guidance. As indicated by the results, we experimentally demonstrated that uniquely designed vascular graft Triplex(®) led to less blood leakage from the vascular graft and less leakage from the needle puncture, although it has fundamental physical properties comparable to those of the vascular grafts using biodegradable material that has been utilized conventionally in clinical settings. Triplex (®)is expected to play its role as a clinically beneficial next-generation vascular graft.
- 1 January 2013
- Published by The Editorial Committee of Annals of Vascular Diseases in Annals of Vascular Diseases
- Vol. 6 (1) , 67-73
Development and Physical Characteristics of Novel Zero-Porosity Vascular Graft “Triplex®^|^quot;
We developed a novel large-diameter graft "Triplex(®)" that uses a non-biodegradable material as a coating material. This time, in order to demonstrate the physical properties of Triplex(®) grafts, we conducted physical tests in accordance with the international guidelines, using the collagen coated vascular grafts (Hemashield, Boston Scientific, Natick, Massachusetts, USA) as the controls. The grafts were tested with regard to strength (burst strength, circumferential tensile strength, longitudinal tensile strength), suture retention strength, integral water permeability, water leakage (needle puncture, after using clamp), and change in luminal diameter following pacing stress according to ISO7198 and FDA guidance. As indicated by the results, we experimentally demonstrated that uniquely designed vascular graft Triplex(®) led to less blood leakage from the vascular graft and less leakage from the needle puncture, although it has fundamental physical properties comparable to those of the vascular grafts using biodegradable material that has been utilized conventionally in clinical settings. Triplex (®)is expected to play its role as a clinically beneficial next-generation vascular graft.
- 1 April 2012
- Vol. 65 (4) , 316-9
[UT modification of the "David-V" procedure].
Valve-sparing aortic root reimplantation with creation of pseudosinuses, so-called "David-V" procedure,is a promising surgical choice to treat annuloaortic ectasia (AAE). We have developed a simple modification of this procedure, which facilitates exposure and also enables good adjustment of the native aortic root anatomy and the graft. In this article we describe our original technique and its mid-term results.
- 1 April 2012
- Vol. 65 (4) , 316-9
[UT modification of the "David-V" procedure].
Valve-sparing aortic root reimplantation with creation of pseudosinuses, so-called "David-V" procedure,is a promising surgical choice to treat annuloaortic ectasia (AAE). We have developed a simple modification of this procedure, which facilitates exposure and also enables good adjustment of the native aortic root anatomy and the graft. In this article we describe our original technique and its mid-term results.
- 1 January 2009
- Vol. 110 (1) , 17-20
[In situ replacement with cryopreserved homografts for infected aortic prostheses].
Although the incidence is rare, aortic prosthetic graft infection represents one of the most serious and challenging complications for cardiovascular surgeons. The basic strategy in the management of aortic graft infection consists of excision of the infected graft, debridement, reconstruction of the distal blood supply, and prolonged antibiotic therapy. As the most reliable procedure, in situ replacement with cryopreserved allografts has been used in our institution since 1998. The overall in-hospital mortality was 43%, higher than in other reports, because of a higher rate of thoracic cases and longer history before surgical intervention in previous reports. All but one survivor have been free from recurrent infection. In situ replacement with a cryopreserved allograft appears to be the best method, although an allograft is not an omnipotent material in patients with abscess formation. Preoperative drainage and irrigation, and allograft replacement with concomitant use of the omentum, would improve the outcome in the future.
- 1 January 2009
- Vol. 110 (1) , 17-20
[In situ replacement with cryopreserved homografts for infected aortic prostheses].
Although the incidence is rare, aortic prosthetic graft infection represents one of the most serious and challenging complications for cardiovascular surgeons. The basic strategy in the management of aortic graft infection consists of excision of the infected graft, debridement, reconstruction of the distal blood supply, and prolonged antibiotic therapy. As the most reliable procedure, in situ replacement with cryopreserved allografts has been used in our institution since 1998. The overall in-hospital mortality was 43%, higher than in other reports, because of a higher rate of thoracic cases and longer history before surgical intervention in previous reports. All but one survivor have been free from recurrent infection. In situ replacement with a cryopreserved allograft appears to be the best method, although an allograft is not an omnipotent material in patients with abscess formation. Preoperative drainage and irrigation, and allograft replacement with concomitant use of the omentum, would improve the outcome in the future.
- 31 October 2006
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (4) , 933-940
Retrograde cerebral perfusion with intermittent pressure augmentation provides adequate neuroprotection: Diffusion- and perfusion-weighted magnetic resonance imaging study in an experimental canine model
- 31 October 2006
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (4) , 933-940
Retrograde cerebral perfusion with intermittent pressure augmentation provides adequate neuroprotection: Diffusion- and perfusion-weighted magnetic resonance imaging study in an experimental canine model
- 31 July 2006
- Published by Elsevier in The American Journal of Surgery
- Vol. 192 (1) , 130-134
Complete coverage of in situ aortograft by total omental pedicle flap as the most reliable treatment of aortoesophageal fistula
- 31 July 2006
- Published by Elsevier in The American Journal of Surgery
- Vol. 192 (1) , 130-134
Complete coverage of in situ aortograft by total omental pedicle flap as the most reliable treatment of aortoesophageal fistula
- 1 July 2004
- Vol. 57, 607-14
[Acute type A aortic dissection].
Current surgical results for acute type A aortic dissection has been getting better, though the mortality rate still remains high, up to 10-15% in Japan. Our strategy consists of #1 make the most use of echography for better understanding of hemodynamics; #2 the extent of replacement depends on the site of initial entry; #3 deep hypothermic circulatory arrest and retrograde cerebral perfusion for brain protection. Between January 2000 and December 2003, 45 consecutive patients were treated. Twelve of them had extended replacement of the arch, and 3 had simultaneous root replacement by means of a composite graft. In hospital mortality was 11% (5 patients). The cause of death was serious organ malperfusion, which had been developed preoperatively, in all patients but 1 who suffered from thoracic aortic obstruction due to newly developed type B aortic dissection. The determinant of surgical mortality in patients with acute type A aortic dissection is the presence of serious organ malperfusion. Rapid diagnosis and less invasive treatment for malperfusion is the key to improve the results.
- 1 July 2004
- Vol. 57, 607-14
[Acute type A aortic dissection].
Current surgical results for acute type A aortic dissection has been getting better, though the mortality rate still remains high, up to 10-15% in Japan. Our strategy consists of #1 make the most use of echography for better understanding of hemodynamics; #2 the extent of replacement depends on the site of initial entry; #3 deep hypothermic circulatory arrest and retrograde cerebral perfusion for brain protection. Between January 2000 and December 2003, 45 consecutive patients were treated. Twelve of them had extended replacement of the arch, and 3 had simultaneous root replacement by means of a composite graft. In hospital mortality was 11% (5 patients). The cause of death was serious organ malperfusion, which had been developed preoperatively, in all patients but 1 who suffered from thoracic aortic obstruction due to newly developed type B aortic dissection. The determinant of surgical mortality in patients with acute type A aortic dissection is the presence of serious organ malperfusion. Rapid diagnosis and less invasive treatment for malperfusion is the key to improve the results.
- 1 January 1996
- Published by The Japanese Society for Cardiovascular Surgery in Japanese Journal of Cardiovascular Surgery
- Vol. 25 (1) , 64-66
Retroperitoneal Approach in the Emergency Treatment of Ruptured Abdominal Aortic Aneurysms.
- 1 January 1996
- Published by The Japanese Society for Cardiovascular Surgery in Japanese Journal of Cardiovascular Surgery
- Vol. 25 (1) , 64-66
Retroperitoneal Approach in the Emergency Treatment of Ruptured Abdominal Aortic Aneurysms.